Minimally Invasive Micro Sclerostomy (MIMS®) is a Stentless, simple and fast Glaucoma treatment which effectively lowers the intraocular pressure (IOP) without the need for major invasive surgery.

A Minimal invasive and Stent-less Treatment Glaucoma Innovation

MIMS® is a rapid and minimal invasive procedure at the forefront of interventional glaucoma treatments. Fewer post-op complications allow for effective IOP management. MIMS® is designed to create a sclerostomy similar to trabeculectomy, the gold standard for incisional glaucoma surgery, but with an approach that is less invasive, in terms of tissue damage, and without any implanted material (stent-less). Therefore, complications relating to hyphema and hypotony (such as flat anterior chamber, choroidal effusions and detachments), which are observed in trabeculectomy are expected to occur at a lower incidence and severity with MIMS®. Other post-operative events are expected to be similar to other minimally invasive, stent-less glaucoma treatments.

How MIMS® Works

Minimally Invasive Micro Sclerostomy (MIMS®) is fast, accessible and effective. MIMS® is intended for the reduction of elevated IOP. It works by inserting a specially designed cutting tool into the sclera and removing a small channel of tissue. This channel will remain open and continuously drain, effectively reducing IOP.

MIMS® advantages:

  • A minimal surgical intervention into the eye with the consequent lower risk of hypotony or injury to the surrounding ocular tissues
  • enables stable post-operative IOP levels
  • Takes short surgical time (few minutes)
  • MIMS® application is simple and easy

A Ready-to-Use Surgical System

MIMS® is a lightweight surgical system intended for use by trained professional ophthalmologists. It’s easy to use and learn, intuitive to operate and requires fewer staff to assist in non-surgical environments. A central control touchscreen demonstrates the surgical parameters, and a foot pedal initiates the precise handheld cutting tool movement.

Precision Glaucoma Treatment Technology

Learn more about Sanoculis and MIMS® surgical device innovation.

Download Specifications ↓

Outstanding Clinical Performance


Min Procedure


IOP Reduction after 12


Medication reduction
at 12 mo.

ZERO Major/serious intra/post-op ocular complications

Major intra/post-op

Explore Clinical Trial Data
  • "The procedure is effective in reducing IOP without medication or complications, improving lives and simplifying treatments for glaucoma."

    Dr. Ike Ahmed

    Ophthalmology MD, Canada

  • "The procedure is effective in reducing the IOP. It is minimally invasive, fast and does not require any stitches or stents under topical local anesthesia. It lasts several minutes and relieves the patient from the need for medications."

    Dr. Lilach Drori

    Head of Glaucoma Service, Barzilai Medical Center, Israel

  • "The procedure is quick, easy to perform and so far, the preliminary results are good and without complications. Every good Cataract surgeon can perform the MIMS surgery combined with Phaco"

    Dr. Beatrice Tiosano

    Director of Ophthalmology, Hillel Yaffe Medical Center, Israel

  • "Having conducted post-op follow-up on patients who have undergone this surgery, the IOP was considerably reduced"

    Dr. Natalya Kovalyuk

    Head of Glaucoma and Cataract Service

1 of 4
  • Mar 31, 2024

    "Minimally invasive micro sclerostomy (MIMS) procedure in the treatment of open-angle glaucoma"

    Read More 
  • May 20, 2021

    "MIMS – An Innovative New Surgical Procedure For Glaucoma"

    Read More 
  • Jul 8, 2020

    "Glaucoma Devices Provide Impressive IOP-lowering Results"

    Read More 
  • Jan 15, 2020

    "MIMS® – a new surgical procedure for glaucoma – simplifies treatment and keeps patients’ options open"

    Read More 
1 of 4